Home » Uncategorized » M2D2 Finalists: Meet Jeremy Jo and Jason Hill, founders of BeTH | Benevolent Technologies for Health

M2D2 Finalists: Meet Jeremy Jo and Jason Hill, founders of BeTH | Benevolent Technologies for Health

The Massachusetts Medical Device Development Center (M2D2) is in the midst of its 2014 New Venture Competition. After weeks of pitches, fifteen finalists have been announced. These finalists have business ventures that M2D2 has deemed “disruptive.” With these fifteen blogs posts, MedTech Boston gives readers a glimpse of the innovators that made it this far in the M2D2 New Venture Competition.

Jeremy Jo and Jason Hill, founders of BeTH | Benevolent Technologies for Health

Jeremy Jo

Jeremy Jo

Jason Hill

Jason Hill

Jeremy Jo and Jason Hill created one of the teams that will move on to the next round of judging in the M2D2 contest. Their company, BeTH | Benevolent Technologies for Health, was chosen from the pool of applicants because of its true potential to disrupt medicine.

What is BeTH all about? These innovators describe their company in a MedTech Boston Q&A:

1. Briefly describe your technology.

BeTH introduces the first ever shape capturing prosthetic device that easily adapts to natural body volume fluctuations.

2. How does it add value to a clinical environment?

Poor socket fit can lead to sores, tissue damage, and even immobility. With the introduction of the BeTH device, amputees will be able to repeatedly obtain a custom fit to increase comfort by simply adjusting the fit of their device. Moreover, the product will reduce overall healthcare costs by saving fabrication time and clinical visits required to obtain an optimum socket fit.

3. How is it disruptive?

This simplifies the overall fitting process by offering custom fit without the cost of custom fabrication. The BeTH liner is the first product that provides a truly dynamic and adjustable fit at the patient level, allowing an amputee to modify the contact of his or her prosthetic device in a matter of minutes. This underlying technology also has potential to impact the greater rehabilitative device market by providing an improved human-device interface.

4. What is your target market?

One in two hundred Americans live in the US with an amputation, with more than 80,000 diabetes-related lower limb amputations performed each year.  There are also another 30,000 limb amputations each year as a result of Peripheral Vascular Disease. In a survey of this amputee population, only 43% were satisfied with the fit of their prosthetic device and 11% do not wear their prosthesis due to discomfort. BeTH aims to improve the comfort, mobility and quality of life for each of these individuals.

5. What are your anticipated funding needs?

BeTH will be looking to raise a large seed round in coming months to continue product development, testing, and hire key personnel.

 

Congratulations and good luck to BeTH, and be sure to stay tuned to catch the other 14 finalists winners featured on MedTech Boston!

M2D2 will be hosting the 2014 New Venture Competition Showcase Event on Wednesday, March 26, 2014. Novel medical device technologies will be presented, followed by a poster and networking session. The grand prize winner will be announced at the follow up winner’s ceremony on April 8th at the offices of Nutter McClennen & Fish in Boston from 4 pm to 8 pm.

Sony Salzman

Sony Salzman

    At MedTechBoston, we are sharing stories about cutting-edge medical innovation. As Managing Editor, I help coordinate our coverage of hackathons and company profiles. I also create content, update our social media and scout stories. I'm part of an ambitious group of people hoping to inspire a tech revolution in medical care.

    Similar posts

    Follow us!

    Send this to a friend